TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Novonesis Plant Biosolutions A/S
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
167,472
|
222,542,957
|
183,371 |
Earnings before taxes |
584,359
|
498,286
|
202,611 |
Total assets |
1,447,910
|
1,531,900,808
|
1,131,970 |
Current assets |
1,180,913
|
1,155,315,517
|
676,585 |
Current liabilities |
293,644
|
290,815
|
210,492 |
Equity capital |
1,085,751
|
1,229,959,460
|
876,652 |
- share capital |
893
|
898,788
|
825 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.0%
|
80.3%
|
77.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
348.9%
|
0.2%
|
110.5% |
Return on assets (ROA) | |||
Current ratio |
402.2%
|
397268.2%
|
321.4% |
Return on equity (ROE) |
53.8%
|
0.0%
|
23.1% |
Change turnover |
-221,235,316
|
222,343,424
|
-22,128 |
Change turnover % |
-100%
|
111432%
|
-11% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.